GSK-3β Promotes Cell Migration and Inhibits Autophagy by Mediating the AMPK Pathway in Breast Cancer

Author:

Guo Lu1,Chen Duankai2,Yin Xing3,Shu Qingfeng2

Affiliation:

1. Jinan University, Guangzhou, Guangdong, P.R. China

2. General Surgery, YouJiang Medical University for Nationalities, Guangxi, P.R. China

3. Wound Regeneration and Vascular Surgery Department of the First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi, P.R. China

Abstract

GSK-3β is a versatile protein kinase participating in many reactions. Currently, there is insufficient understanding of its influence on breast cancer (BC). In order to explore its influence on migration and invasion in BC, we investigated its expression in BC cell lines using qRT-PCR and Western blot (WB). Immunohistochemistry (IHC) was used to examine the potential of GSK-3β to predict clinical outcome in BC patients. GSK-3β knockdown was achieved using an shRNA plasmid vector in T47D cells. Our research explored the biological reactions and downstream pathways involved. We found excessive GSK-3β expression in BC tissues, which was correlated with worse clinicopathological parameters and clinical outcome. Progression of BC was suppressed by GSK-3β knockdown. Furthermore, suppression of GSK-3β function led to a noticeable decrease in ATP generation, and this was associated with stimulation of AMP-activated protein kinase (AMPK) in T47D cells. Activation of AMPK, a typical sign of autophagy stimulation, was triggered after suppression of GSK-3β function, in parallel with increased generation of LC3 II. Our findings therefore indicate that GSK-3β participates in regulation of migration as well as stimulation of autophagy via mediating activation of the AMPK pathway. This suggests that GSK-3β has potential as a predictor of clinical outcome and as a target for BC therapy.

Publisher

Cognizant, LLC

Subject

Cancer Research,Oncology,General Medicine

Reference32 articles.

1. Triple-negative breast cancer and the potential for targeted therapy;Pharmacogenomics,2017

2. Health-related quality of life in Asian patients with breast cancer: A systematic review;BMJ Open,2018

3. Current challenges of metastatic breast cancer;Cancer Metastasis Rev.,2016

4. Breast intervention and breast cancer treatment options;Radiol Technol.,2015

5. Breast cancer: Major risk factors and recent developments in treatment;Asian Pac J Cancer Prev.,2014

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3